Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	12.69M -56.9%
Revenue (ttm)	71.39M +4.3%
Net Income	1.72M -91.6%
EPS	0.06 -92.0%
Shares Out	2.64B
PE Ratio	0.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,000
Average Volume	28,521
Open	0.0052
Previous Close	0.0038
Day's Range	0.0048 - 0.0052
52-Week Range	0.0025 - 0.0111
Beta	-2.01
RSI	53.30
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Employees: 533
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS